On ECHEMI
Home > Drugs > Tranexamic acid Registered Holders
Tranexamic acid structure

Tranexamic acid structure

Tranexamic acid

Tranexamic acid (Transamin) is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM. Target: OthersTranexamic acid is a synthetic derivative of the amino acid lysine. Tranexamic acid is frequently used in surgeries with high risk of blood loss such as cardiac, liver, vascular and large orthopedic procedures. Its oral form is now being evaluated for use in outpatient conditions involving heavy bleeding.Toxicity/Adver

Find 38 Related Holders

MALLADI DRUGS AND PHARMACEUTICALS LIMITED
European Union European Union

API Registration Country

API Active
AMI LIFESCIENCES PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
Hunan Dongting Pharmaceutical Co. Ltd
European Union European Union

API Registration Country

API Active
KYOWA PHARMA CHEMICAL CO., LTD.
European Union European Union

API Registration Country

API Active
ASAHI KASEI FINECHEM CO., LTD.
European Union European Union

API Registration Country

API Active
ZHEJIANG BAMBOO PHARMACEUTICALS CO LTD
United States United States

API Registration Country

API Active
JIANGSU TIANHE PHARMACEUTICAL CO., LTD.
European Union European Union

API Registration Country

API Active
ALP PHARM BEIJING CO LTD
United States United States

API Registration Country

API Active
HUNAN DONGTING PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
Changzhou Yinsheng Pharmaceutical Co.,Ltd.
Japan Japan

API Registration Country

API Active
Recommended Suppliers of Tranexamic acid
View 205 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.